top of page
  • Yaser Alobeid

Recalls Announced for Metformin Extended Release Tablets

Pending an ongoing FDA investigation, which commenced in December 2019, various pharmaceutical companies have announced voluntary recalls for Metformin Extended Release products. Test results revealed high levels of N-nitrosodimethylamine (NDMA), above the acceptable intake limit in some lots. NMDA is considered a probable human carcinogen.

How will I know if my medication was recalled?

The current recalls only apply to the extended release tablets. Patients currently prescribed an extended release version of Metformin, should consult with their doctor or pharmacist to determine if their medication is affected by the recent recalls. A list of recalled Metformin ER products and lot numbers may also be accessed with the following link:

Should I stop taking my medication?

Always consult your doctor prior to stopping any medication. As always, Family Medicine of Merrillville is happy to address any concerns you may have regarding the recent Metformin recalls, please feel free to contact us at 219-736-0900.

131 views0 comments

Recent Posts

See All
bottom of page